Literature DB >> 1827789

Abnormal high-energy phosphate metabolism in human muscle phosphofructokinase deficiency.

L A Bertocci1, R G Haller, S F Lewis, J L Fleckenstein, R L Nunnally.   

Abstract

We studied the pattern of high-energy phosphate metabolism in five patients with phosphofructokinase deficiency (PFKD) and five healthy subjects (HS) during graded rhythmic handgrip performed for 5 min at 17, 33, 50, and 100% of maximal voluntary contraction (MVC). The range of MVC was similar in both groups. Force production was recorded, and intracellular concentrations of phosphorus compounds and pH were measured in the flexor digitorum profundus of the active forearm. At exercise intensities greater than or equal to 50% MVC, changes in concentrations of high-energy phosphate metabolites were abnormal in PFKD. During maximal effort, [ADP], calculated from the creatine kinase reaction, was 64.3 +/- 13.5 (SE) mumol/kg in PFKD vs. 25.7 +/- 4.0 in HS (P less than 0.05). Ammonia (NH3), a product of AMP deamination and an index of muscle [AMP], increased approximately twofold more in venous effluent during maximal forearm exercise in PFKD than in HS (P less than 0.05). Phosphocreatine concentration was 9.4 +/- 1.3 (SE) mmol/kg in HS and 13.0 +/- 1.7 in PFKD (P less than 0.05). Inorganic phosphate concentration was 15.8 +/- 1.4 mmol/kg in HS and 7.4 +/- 0.5 in PFKD (P less than 0.05). During strenuous exercise, PFKD patients exhibit an impairment in the rephosphorylation of ADP related to a subnormal oxidative capacity, an absence of glycolysis, and an attenuated breakdown of phosphocreatine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827789     DOI: 10.1152/jappl.1991.70.3.1201

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

Review 1.  In vivo MR investigation of skeletal muscle function in small animals.

Authors:  B Giannesini; P J Cozzone; D Bendahan
Journal:  MAGMA       Date:  2004-12-10       Impact factor: 2.310

2.  31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients.

Authors:  G E Moore; L A Bertocci; P L Painter
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

3.  Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.

Authors:  Emil Malucelli; Raffaele Lodi; Andrea Martinuzzi; Caterina Tonon; Bruno Barbiroli; Stefano Iotti
Journal:  Dyn Med       Date:  2005-06-06

4.  Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.

Authors:  Miguel García; Anna Pujol; Albert Ruzo; Efrén Riu; Jesús Ruberte; Anna Arbós; Anna Serafín; Beatriz Albella; Juan Emilio Felíu; Fátima Bosch
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

5.  Muscle phosphoglycerate mutase (PGAM) deficiency in the first Caucasian patient: biochemistry, muscle culture and 31P-MR spectroscopy.

Authors:  G Vita; A Toscano; N Bresolin; G Meola; F Fortunato; A Baradello; B Barbiroli; C Frassineti; P Zaniol; C Messina
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.